Anticancer activity of ethanolic extract of propolis on AGS cell line by Amini-Sarteshnizi, Nematallah. et al.
Journal of HerbMed Pharmacology
Journal homepage: http://www.herbmedpharmacol.com                
J HerbMed Pharmacol. 2015; 4(1): 29-34.
Anticancer activity of ethanolic extract of propolis on 
AGS  cell line
*Corresponding author: Teimori H (PhD), Cellular and Molecular Research 
Center, Shahrekord University of Medical Science, Shahrekord, Iran, E-mail: 
hteimori@skums.ac.ir 
Introduction
Propolis is a natural, resinous and strongly adhesive 
substance that is collected from blooms and leaves of trees 
and plants by honeybees and is combines with pollen 
and enzymes secretions of bees (1). Bees use propolis 
as a general-purpose sealer to smooth out the internal 
walls of the hive and also as a protective barrier against 
intruders (2). Overall, propolis is composed of 50% 
resin and vegetable balsam, 30% wax, 10% essential and 
aromatic oils, 5% pollen and 5% various other substances, 
including organic debris (2). Wax and organic debris are 
removed throughout biological processes that are usually 
done by ethanol extracts, and balsam thus obtained, 
contains the bulk of propolis bioactive constituents. 
Over 300 compounds among which polyphenols, 
terpenoides, steroids, sugars and amino acids have 
been identified in raw propolis. The frequency of these 
compounds is influenced by botanical and geographical 
factors, as well as by the collection of season (1,3). 
Propolis is considered responsible for the low presence 
of bacteria and moulds within the hive. The action 
against microorganisms is an important characteristic 
of propolis and humans have used it for centuries for its 
pharmaceutical properties (4,5). Besides its antibacterial, 
antifungal, antiviral characteristics, propolis presents 
many other biological activities including antioxidant, 
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Implication for health policy/practice/research/medical education:
Ethanolic extract of propolis prevents growth and proliferation of AGS cells due to strong cytotoxic effects against tumor cells. 
Therefore, this compound of honey bee might be useful in developing chemotherapeutic agents for treating human gastric cancer.
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Introduction: Propolis is a natural product derived from various plant resins collected by 
honeybees, and has been used as a folk medicine for centuries. Propolis has been reported to exhibit 
a broad spectrum of activities including antibacterial, antifungal, antiviral, anti-inflammatory, 
antioxidant, hepatoprotective, and anticancer properties. The aim of this study was to investigate 
the effect of ethanolic extract of propolis (EEP) obtained from Dinaran area (Iran) on AGS human 
gastric cancer cell line.
Methods: The ethanolic extract of samples was obtained by ethanol 96% and pure extract was 
dissolved in dimethyl sulfoxide (DMSO) and used for experiments. The cytotoxic effects of various 
concentrations of EEP on AGS cells were investigated by MTT assay test after 24, 48, and 72 hours 
and compared with control cells.
Results: The EEP inhibited the growth and proliferation of AGS human gastric cancer cell line. 
The antiproliferative effects were revealed in a dose and time-dependent manner. The IC50 values 
were recorded as 60, 30, and 15 (µg/ml) in treatment times of 24, 48 and 72 hours, respectively.
Conclusion: These findings indicated that the native EEP has strong antiproliferative effects 
against cancerous AGS cells. Thus, propolis and related products may provide a novel approach to 
the chemoprevention and treatment of human gastric cancer. 
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antiinflammatory, antitumor, hepatoprotective, local 
anesthetic, immunostimulatory and anti-mutagenic (2,6-
8). For this, propolis is used as a generic remedy in folk 
medicine, as a constituent of biocosmetics and healthy 
foods, and for numerous other purposes (4,5,7). Propolis 
is relatively non-toxic, with a non-observed effect level 
(NOEL) of 1400 mg/kg body weight/day in a mouse 
study (2).
Due to geomorphologic characteristics, the plants of 
Dinaran area (Iran) exhibit high biodiversity with many 
endemic plants, so the propolis collected from this region 
is likely to contain biologically active compounds. In 
literature scarce data can be found about the composition, 
antibacterial, anticancer and antioxidant properties of 
Iranian propolis extracts and no data at all about propolis 
from Dinaran in the literature.
Gastric cancer is the fourth most important cancer 
and the second leading cause of cancer-related deaths 
worldwide (9), including one million mortalities per year 
worldwide (10). Cancer is one of the most important 
healthcare problems in Iran. After road accidents and 
cardiovascular diseases, cancers are the third leading cause 
of mortalities in Iran. More than 30 000 individuals die 
per year because of cancer, and it is estimated that more 
than 70 000 individuals per year develop cancer in Iran. 
Out of all cancers that have been registered to date, skin 
cancer, breast carcinoma, gastric cancer, colorectal cancer, 
bladder cancer, hematopoietic system cancer, prostate 
cancer, esophagus cancer, lymph nodes cancer, and 
lungs cancer are the most prevalent. In Iran, over 50% of 
prevalent cancers are gastrointestinal tract-related, among 
which gastric cancer is the most prevalent. Most gastric 
cancers are developed in the elderly, and since Iranian 
population is relatively young, the incidence rate of and 
the mortality due to this fatal disease may be increase 
rapidly in the near future as life expectancy increases. 
Therefore, in light of the importance of fighting with 
this fatal disease, a program for controlling and treating 
it seems necessary (11). In the present study, anticancer 
activity of the ethanolic extract of propolis collected from 
Dinaran area (Iran) was investigated on AGS human 
gastric cancer cell line.
Materials and Methods 
Chemicals and reagents
Dulbecco’s modified Eagle’s medium (DMEM), fetal bovine 
serum (FBS), penicillin-streptomycin, and trypsin-EDTA 
were purchased from Gibco Co (Invitrogen, Carlsbad, 
CA, USA). Dymethyle sulfoxide (DMSO) was purchased 
from Sigma Chemical Co. (St. Louis, MO, USA). MTT 
(3-(4, 5-dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium 
bromide) assay Kit was purchased from BIO IDEA Co 
(Tehran-Iran). 
Preparation of propolis extracts
Propolis samples were collected as fresh from Dinaran 
area (Iran) and kept at -20°C. Ethanolic extract of propolis 
(EEP) was prepared according to Kalogeropoulos and 
Konteles method (12). Briefly, the collected propolis 
samples were frozen for 24 h. Then, they were grounded 
by moulinex vivacio grinder, and 50 g of the obtained 
powder was dissolved in 500 cc ethanol solution (V/V) 
in a dark glass container and incubated at 37°C for 14 
days. The solution was shaken twice a day throughout 
the incubation period. After 14 time period, the obtained 
extract was filtered by Whatman filter paper (No. 4). To 
remove waxes and less soluble substances, the suspensions 
were subsequently frozen at -20°C for 24 hours, then 
filtered with Whatman (NO.4) filter paper. The freezing-
filtration cycle was repeated three times. The final 
filtration led to represent the balsam (tincture) of propolis 
and is referred to as EEP (ethanolic extract of propolis). 
The solutions were evaporated to near dryness on a rotary 
evaporator (EYELA Rotary Evaporator N-100) under 
reduced pressure at 40°C. The remaining extract was 
incubated at 37°C for two weeks till the remainder of the 
ethanol was evaporated and the resulting powders were 
kept at -20°C. For experimental treatments, EEP at 100 
mg/ml concentration was dissolved in DMSO as solvent 
and stored at -20°C.
Cell line and culture
AGS human gastric cancer cell-line was purchased from 
National Cell Bank of Iran (NCBI), Pasteur Institute of 
Iran (NCBI, C131). AGS cells were grown in Dulbecco’s 
modified Eagle’s medium (DMEM) (Gibco, USA) 
supplemented with 10% (v/v) heat-inactivated fetal bovine 
serum (FBS) (Gibco, USA) and 1% penicillin-streptomycin 
(Gibco, USA) in an incubator with humidified air with 
5% CO2 at 37°C (13). For maintaining in the exponential 
growth phase, the cells were passaged at 70%-80% 
confluence once a week by trypsin-EDTA (Gibco, USA) 
(14). EEP were dissolved in DMSO as solvent and were 
prepared as 100 mg/ml stock solution and were kept at 
100 ml volumes at -20°C. Different concentrations of EEP 
were prepared with DMEM containing FBS 10% just prior 
to AGS cells treatment.
Cell proliferation assays
Cell viability was measured by MTT assay kit (BIO IDEA 
Co. Tehran, Iran). The viability of AGS cells was measured 
in different concentrations of EEP (µg/ml) within 24, 
48 and 72 hours. Cells were seeded into 96 well plates 
at a density of 5000 cells per well and the plates were 
incubated at 37°C temperature in a humidified incubator 
containing 5% CO2 for 24 hours. After 24 hours, the 
medium was removed and the cells were treated for 
24, 48 and 72 hours with medium containing different 
concentrations (0, 10, 15, 20, 30, 40, 50, 60, 80, and 100 
μg/ml) of EEP. The cells that were not treated with EEP 
were considered as control. The same volume of DMSO 
was used as the vehicle control for EEP experiments at a 
final concentration of 0.1%. Each EEP concentration was 
represented by 3 wells and replicated thrice. After 24, 48 
and 72 hours, AGS cells viability was measured by MTT 
Assay kit according to manufacture protocol. Finally, 
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optical density (OD) of each well was measured by an 
ELISA reader (AWARENESS-State Fax, USA) at 570-nm 
wavelength and the rate of viability (%) was calculated by 
the following formula:
 
Cell viability rate (%) = OD of treated cells/OD of control 
cells × 100
Statistical analysis 
The statistical analysis of MTT assay data for different 
concentrations of EEP within 24, 48, 72 hours that 
calculated as viability percent was done by SPSS 19 using 
one-way ANOVA followed by Dennett’s test. P<0.05 was 
considered as statistically significant.
Results
The cytotoxic effects of various concentrations of EEP on 
AGS cells for 24 hours are shown in Figure 1. The viability 
of AGS cells was decreased in a dose-dependent manner 
by low doses of EEP. Morphological investigation by light 
microscope indicated that after 4 hours treatment at 80 and 
100 µg/ml concentrations, EEP induced morphological 
changes in AGS cells. Twenty-four hours after treatment 
with all studied EEP concentrations, AGS cells viability 
decreased significantly. The highest inhibition of the cells 
growth was seen after treatment with EEP at 80 and 100 
µg/ml with reductions of approximately 68.4% and 80.6%, 
respectively. Overall, the viability of AGS cells was further 
decreased by higher doses of EEP (0–100 µg/ml), with an 
IC50 of approximately 60 µg/ml (Figure 1).
 Similarly, 48 hours after treatment with EEP, AGS cells 
viability decreased in a concentration dependent manner 
with an IC50 of approximately 30 µg/ml. The highest 
inhibition of growth was observed after treatment with 
EEP at 80 and 100 µg/ml concentrations with a reduction 
of about 93.4% and 100% respectively (Figure 2).
High significant inhibition of AGS cells viability was 
observed at 72 hours treatment with EEP. After treatment 
for 72 hours with EEP, the highest reduction in viability 
was observed at 80 and 100 µg/ml concentrations with a 
reduction of approximately 100%, and followed by 60 µg/
ml concentration with viability reduction of approximately 
99%, respectively. IC50 value for 72 hours EEP treatment 
was obtained as approximately 15 µg/ml (Figure 3).
Analysis of the data by Dunnett’s test indicated that during 
24, 48 and 72 hours durations, there was significant 
differences between control samples and all treated samples 
(P<0.001). In addition, at each treated concentration, 
there was a significant difference between 24, 48 and 72 
hours durations (P<0.001). The associations between AGS 
cells growth and the concentrations of EEP indicated that 
this extract reduced viability of AGS cells in a time and 
dose-dependent manner (Figures 4). The IC50 of EEP on 
AGS human gastric cancer cell line in 24, 48 and 72 hours 
significantly decreased in time dependent manner. 
Discussion
Figure 1. The effect of EEP at 0, 10, 15, 20, 30, 40, 50, 60, 80 and 
100 µg/ml concentrations on AGS human gastric cancer cell line in 
24 hours. Dunnett’s test indicated a significant difference between 
different treated concentrations and control within 24 hours (P<0.001).
Figure 2. The effect of EEP at 0, 10, 15, 20, 30, 40, 50, 60, 80 and 
100 µg/ml concentrations on AGS human gastric cancer cell line in 
48 hours. Dunnett’s test indicated a significant difference between 
different treated concentrations and control within 48 hours (P<0.001).
Figure 3. The effect of EEP at 0, 10, 15, 20, 30, 40, 50, 60, 80 and 
100 concentrations on AGS human gastric cancer cell line in 72 hours. 
Dunnett’s test indicated a significant difference between different 
treated concentrations and control within 72 hours (P<0.001).
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In recent years, the understanding of tumor biology has 
considerably changed the paradigm of cancer therapy 
and allowed the identification of new therapeutic targets, 
with development of new methods and therapeutic agents 
(15). Over the years, natural products have been used as 
promising sources for discovery of new pharmaceutical 
agents (16,17). Propolis, has been extensively studied for 
its biological properties (18), especially antitumor activity 
(19-25); nevertheless, there are no studies exploring 
Dinaran propolis with the purpose of gastric cancer 
therapy (24,26). In the present study we aimed to analyze 
the antitumoral activity of Dinaran propolis samples and 
we found that this EEP induced strong cytotoxic effect 
with decreases the viability and growth of AGS cells.
The antiproliferative activity of this extract was similar 
to that of propolis extracts exerting biological activities 
in other carcinoma cell types. For example, Dutch and 
Brazilian propolis exert antiproliferative activity in murine 
26-L5 colon carcinoma, murine B16-BL6 melanoma, 
human HT1080 fibrosarcoma, and human A549 lung 
adenocarcinoma cell lines (27). Also, the Chilean propolis 
inhibited the growth of human KB mouth epidermoid 
carcinoma and DU145 androgen intensive prostate 
carcinoma cell lines (28). Therefore, findings of the 
presents study, in agreement with the above information, 
demonstrate a wide range of anticancer properties of 
propolis extract. 
Over 300 compounds have been identified in propolis 
samples including flavonoids, polyphenols, phenolic 
aldehydes, terpenoides, coumarins, amino acids, steroids 
and non biological compounds (22). The propolis 
products obtained from European and Chinese consist 
of flavonoid types and phenolic acid esters (29), while 
Brazilian propolis consists of artepillin C, terpenoids and 
p-coumaric acid derivatives (30,31). Benzyl caffeate and 
phenethyl caffeate isolated from Chinese propolis induced 
Figure 4. Comparison of the effect of EEP at different 
concentrations on AGS human gastric cancer cell line in 24, 48 
and 72 hours. Dunnett’s test indicated a significant difference 
between different treated concentrations and control within the 
periods as well as among the periods (P<0.001).
antiproliferative activity in rats colon carcinoma cells 
(29). Ethanolic  extract derived from Dutch and Chinese 
propolis exhibited significant cytotoxicity while Brazilian 
and Peruvian propolis extracts exerted low toxicity (32).
One of the specifications of cancer therapies is ability 
to induction apoptosis and cell cycle arrest in tumor 
cells. Other studies suggested that propolis compounds 
could inhibit cell proliferation or induce apoptosis by 
suppressing cyclin complexes and proteins associated with 
cyclin, increasing the levels of cyclin-dependent kinase 
(Cdk) inhibitors such as p16, p21 and p27 proteins and 
cell cycle arrest, activation of Bax, p53 and p21 proteins, 
p38MAPK, JNK and ERK kinases, release cytochrome C 
into cytosol and activation of caspase cascades in tumor 
cells. These effects are not dependent on the type of tumor 
cell. The results of this studies also suggest the inhibition 
of NF-kB activation, the suppression of antiapoptotic 
proteins, such as IAP, c-FLIP, Akt kinase, and the initiation 
of extrinsic pathway of apoptosis by induction of TRAIL 
and Fas receptor stimulation in cancer cells (33).
Findings of present study that the EEP caused inhibition 
of AGS cells growth even at low concentrations, suggests 
that this extract contains compounds with anticancer 
activities. The components of propolis are associated 
with phytogeographical specifications including plant 
resources, distribution of vegetation and seasonal periods 
(22). Also several studies have confirmed the differences 
in percentages of individual components of propolis, 
depending on the origin of the plants from which the 
resin is collected and the species of bees, therefore, 
It is recommended to identify and isolate the active 
compounds of this extract to developing new drugs for 
gastric and other cancer therapies.
Overall, our results strongly suggest that the EEP caused 
dose- and time-dependent decreases in rates of AGS cell 
growth and proliferation. Therefore, as a strong bioactive 
and promising source for new drugs development, 
this Propolis and its compounds could be potentially 
useful as chemotherapeutic or chemopreventive gastric 
anticancer drugs.
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